Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Carl Lebel > Profile

Carl Lebel

Affiliations

  • Chief Development Officer at Frequency Therapeutics Inc. (FREQ), 2023-01-27
  • Chief Scientific Officer at Otonomy Inc. (OTIC), 2016-11-22
  • Director at Nurx Pharmaceuticals Inc. (NUXP.OB), 2010-02-24
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
Frequency Therapeutics Inc.
 FREQ $1.52 4,421 Officer 26,343 2022-07-06 Filing
Frequency Therapeutics Inc.
 FREQ $3.53 1,069 Officer 11,126 2022-02-22 Filing
Frequency Therapeutics Inc.
 FREQ $3.87 974 Officer 12,195 2022-02-18 Filing
Frequency Therapeutics Inc.
 FREQ $4.19 901 Officer 13,169 2022-02-17 Filing
Frequency Therapeutics Inc.
 FREQ $4.43 831 Officer 14,070 2022-02-16 Filing